Multiple myeloma cases are increasing in Asia, with the region currently contributing to more than 35% of the projected global incidence, with China, India, and Japan comprising more than a quarter of the cases.
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
Read more